A case of cerebellar embolic infarction in thyrotoxic atrial fibrillation.
- Author:
So Jean CHOI
1
;
Chang Ryoul LEE
;
Jun Ho LEE
;
Dong Suk LEE
;
Seo Ryong HAN
;
Woo Seung KIM
;
Seong Pyo SON
Author Information
1. Department of Internal Medicine, St. Benedict Hospital, Pusan, Korea.
- Publication Type:Case Report
- Keywords:
Nimesulide;
Hypersensitivity;
Hepatitis;
toxic
- MeSH:
Atrial Fibrillation*;
Central Nervous System;
Cerebrum;
Embolism;
Heart;
Heart Failure;
Hepatitis;
Humans;
Hypersensitivity;
Hypertension;
Infarction*;
Thromboembolism;
Thyrotoxicosis;
Ventricular Dysfunction, Left
- From:Korean Journal of Medicine
2000;59(2):192-197
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Atrial fibrillation occurs in 10 to 25% of patients with thyrotoxicosis. Several recent studies have found a high frequency of cerebral thromboembolism in such patients. Thus anticoagulation has been recommended for patients with thyrotoxic atrial fibrillation to prevent embolic complications especially when associated with predictors of an increased risk of arterial thromboembolism in nonrheumatic atrial fibrillation such as recent congestive heart failure, history of hypertension, previous thromboembolism, left atrial enlargement, and global left ventricular dysfunction. Most reported cases of embolic events involving central nervous system in thyrotoxic atrial fibrillation affected cerebrum, and cerebellar embolic infarction from the heart was rarely seen. We herein report our experience of a case of cerebellar embolism in thyrotoxic atrial fibrillation.
